-+ 0.00%
-+ 0.00%
-+ 0.00%

bioAffinity CEO to present at H.C. Wainwright Global Investment Conference

PUBT·09/03/2026 20:30:39
Listen to the news
bioAffinity CEO to present at H.C. Wainwright Global Investment Conference
  • bioAffinity Technologies CEO Maria Zannes will present at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026.
  • Corporate update to address strategic milestones, commercial traction for the CyPath Lung test, and progress on its broader diagnostic platform.
  • One-on-one meetings with investors scheduled during the conference.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609031630BIZWIRE_USPR_____20260903_BW308081) on September 03, 2026, and is solely responsible for the information contained therein.